Helyx Industries FY25 net loss narrows to EUR 4.38 million; net sales more than doubled to EUR 1.93 million

• Helyx Industries posted a net loss of EUR 4.38 million, narrowing from EUR 5.94 million a year earlier.
• Net sales more than doubled to EUR 1.93 million, while total production value climbed 79.72% to EUR 2.23 million.
• Operating loss narrowed to EUR 4.35 million from EUR 5.91 million.
• Net financial expense was EUR 26,690, versus EUR 28,690 in the prior year.
• 2025 commercial updates included a CapeBIO distribution deal, a Gates Foundation-backed malaria project phase two, and a confirmed EUR 758,560 NGS order proposal.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Helyx Industries S.p.A. published the original content used to generate this news brief on September 24, 2026, and is solely responsible for the information contained therein.